Article Details
Retrieved on: 2025-06-30 14:22:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Felzartamab is a monoclonal antibody targeting CD38+ plasma cells, the source of pathogenic anti-PLA2R antibodies. Unlike broad-spectrum ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here